Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo
Liying Chena,
Zhi Chen*ab,
Shuang Zhenga,
Luhui Fana,
Lixin Zhuac,
Jiandong Yua,
Chaoyuan Tanga,
Qi Liud and
Yang Xiong*a
aDepartment of Pharmaceutical Science, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 311400, Zhejiang, China
bThe First People’s Hospital of Jiande, Jiande 311600, Zhejiang, China
cZhejiang Institute for Food and Drug Control, Hangzhou 310004, Zhejiang, China
dDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
First published on 12th August 2024
Abstract
Correction for ‘Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo’ by Liying Chen et al., RSC Adv., 2020, 10, 34928–34937, https://doi.org/10.1039/d0ra00184h.
The authors regret that due to an image selection and processing error, the panel of group B-53 min and group C-93 min were incorrect in Fig. 4. The corrected version of Fig. 4 is provided below:
 | ||
| Fig. 1 BLI of MCF-7/DOXFluc tumor-bearing nude mice at different time points within 115 min after intraperitoneal injected D-luc with a dose of 100 mg kg−1 (n = 3). (A) PBS group (i.p., QD). (B) The low ELE concentration group (ELE 10 mg kg−1, i.p., QD). (C) The high ELE concentration group (ELE 25 mg kg−1, i.p., QD). | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2024 |